Cited by 1,254Diabetes Management and ResearchDiabetes Management and EducationDiabetes and associated disorders

The DOI matches its Crossref record; 24 of the 25 references it cites were found in a registry or an index.

Current State of Type 1 Diabetes Treatment in the U.S.: Updated Data From the T1D Exchange Clinic Registry

Miller, Kellee M., Foster, Nicole C., Beck, Roy W., Bergenstal, Richard M., DuBose, Stephanie N., DiMeglio, Linda A., Maahs, David M., Tamborlane, William V.·2015·Diabetes Care

DOI 10.2337/dc15-0078

Open this paper in CoChat — free account

Abstract

To examine the overall state of metabolic control and current use of advanced diabetes technologies in the U.S., we report recent data collected on individuals with type 1 diabetes participating in the T1D Exchange clinic registry. Data from 16,061 participants updated between 1 September 2013 and 1 December 2014 were compared with registry enrollment data collected from 1 September 2010 to 1 August 2012. Mean hemoglobin A1c (HbA1c) was assessed by year of age from <4 to >75 years. The overall average HbA1c was 8.2% (66 mmol/mol) at enrollment and 8.4% (68 mmol/mol) at the most recent update. During childhood, mean HbA1c decreased from 8.3% (67 mmol/mol) in 2–4-year-olds to 8.1% (65 mmol/mol) at 7 years of age, followed by an increase to 9.2% (77 mmol/mol) in 19-year-olds. Subsequently, mean HbA1c values decline gradually until ∼30 years of age, plateauing at 7.5–7.8% (58–62 mmol/mol) beyond age 30 until a modest drop in HbA1c below 7.5% (58 mmol/mol) in those 65 years of age. Severe hypoglycemia (SH) and diabetic ketoacidosis (DKA) remain all too common complications of treatment, especially in older (SH) and younger patients (DKA). Insulin pump use increased slightly from enrollment (58–62%), and use of continuous glucose monitoring (CGM) did not change (7%). Although the T1D Exchange registry findings are not population based and could be biased, it is clear that there remains considerable room for improving outcomes of treatment of type 1 diabetes across all age-groups. Barriers to more effective use of current treatments need to be addressed and new therapies are needed to achieve optimal metabolic control in people with type 1 diabetes.

Integrity signals

Registry

Crossref · 10.2337/dc15-0078

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview
Nathan, D. M., & for the DCCT/EDIC Research Group (2014) · Diabetes Care · doi:10.2337/dc13-2112 · Cited by 1,832
Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial
(1994) · The Journal of Pediatrics · doi:10.1016/s0022-3476(94)70190-3 · Cited by 1,654
Continuous glucose monitoring and intensive treatment of type 1 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805017 · Cited by 1,559
Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus
The Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.287.19.2563 · Cited by 941
Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes
Bergenstal, R. M., Tamborlane, W. V., Ahmann, A., Buse, J. B., Dailey, G., Davis, S. N., Joyce, C., Peoples, T., Perkins, B. A., Welsh, J. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002853 · Cited by 894
The burden of diabetes mellitus among US youth: prevalence estimates from the SEARCH for Diabetes in Youth Study
SEARCH for Diabetes in Youth Study Group (2006) · Pediatrics · doi:10.1542/peds.2006-0690 · Cited by 726
The Burden of Diabetes Mellitus Among US Youth: Prevalence Estimates From the SEARCH for Diabetes in Youth Study
Stockman, J. A. (2008) · Yearbook of Pediatrics · doi:10.1016/s0084-3954(08)70503-7 · Cited by 595
Evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A1c levels in T1D exchange clinic registry participants
Miller, K. M., Beck, R. W., Bergenstal, R. M., Goland, R. S., Haller, M. J., McGill, J. B., Rodriguez, H., Simmons, J. H., Hirsch, I. B., & for the T1D Exchange Clinic Network (2013) · Diabetes Care · doi:10.2337/dc12-1770 · Cited by 505
Self-citation
The T1D exchange clinic registry
Beck, R. W., Tamborlane, W. V., Bergenstal, R. M., Miller, K. M., DuBose, S. N., Hall, C. A., & for the T1D Exchange Clinic Network (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1561 · Cited by 456
Self-citation
Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality
Orchard, T. J., Nathan, D. M., Zinman, B., Cleary, P., Brillon, D., Backlund, J.-Y. C., & Lachin, J. M. (2015) · JAMA · doi:10.1001/jama.2014.16107 · Cited by 437

Show all 25 references

Sorted by citations

Items 501–600 of 1,002

Trajectories in HbA1c and other risk factors among adults with type 1 diabetes by age at onset
Edqvist, J., Rawshani, A., Rawshani, A., Adiels, M., Franzén, S., Bjorck, L. M., Svensson, J., Lind, M., Sattar, N. A., & Rosengren, A. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002187 · Cited by 25
Here for You: A Review of Social Support Research in Young Adults With Diabetes
Carreon, S. A., Duran, B., Tang, T. S., Streisand, R. M., Anderson, B. J., Lyons, S. K., McKay, S. V., & Hilliard, M. E. (2021) · Diabetes Spectrum · doi:10.2337/dsi21-0013 · Cited by 24
Learning experience design of an mHealth self-management intervention for adolescents with type 1 diabetes
Schmidt, M., Lu, J., Luo, W., Cheng, L., Lee, M., Huang, R., Weng, Y., Kichler, J., Corathers, S. D., Jacobsen, L. M., et al. (2022) · Educational Technology Research and Development · doi:10.1007/s11423-022-10160-6 · Cited by 27
“Two prominent behavioral factors include (1) stress and burnout and (2) executive dysfunction related to time management and planning (Miller et al., 2015; Mulvaney et al., 2011; Perez et al., 2017).”
Background
24-Hour Movement Behaviours (Physical Activity, Sedentary Behaviour and Sleep) Association with Glycaemic Control and Psychosocial Outcomes in Adolescents with Type 1 Diabetes: A Systematic Review of Quantitative and Qualitative Studies
Patience, M., Janssen, X., Kirk, A. F., McCrory, S., Russell, E., Hodgson, W., & Crawford, M. M. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20054363 · Cited by 22
Interrupting prolonged sitting with frequent short bouts of light‐intensity activity in people with type 1 diabetes improves glycaemic control without increasing hypoglycaemia: The SIT‐LESS randomised controlled trial
Campbell, M. D., Alobaid, A. M., Hopkins, M., Dempsey, P. C., Pearson, S. M., Kietsiriroje, N., Churm, R., & Ajjan, R. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15254 · Cited by 23
A randomized clinical trial aimed at preventing poor psychosocial and glycemic outcomes in teens with type 1 diabetes (T1D)
Weissberg-Benchell, J. A., Rausch, J. R., Iturralde, E., Jedraszko, A. M., & Hood, K. K. (2016) · Contemporary Clinical Trials · doi:10.1016/j.cct.2016.05.006 · Cited by 22
Cost-effectiveness of G5 Mobile continuous glucose monitoring device compared to self-monitoring of blood glucose alone for people with type 1 diabetes from the Canadian societal perspective
Chaugule, S., & Graham, C. (2017) · Journal of Medical Economics · doi:10.1080/13696998.2017.1360312 · Cited by 22
Depression Screening of Adolescents With Diabetes: 5-Years of Implementation and Outcomes
Corathers, S. D., Mara, C. A., Chundi, P. K., & Kichler, J. (2019) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2019.01.013 · Cited by 20
Designing Online and Mobile Diabetes Education for Fathers of Children With Type 1 Diabetes: Mixed Methods Study
Albanese-O’Neill, A., Schatz, D., Thomas, N., Bernhardt, J. M., Cook, C. L., Haller, M. J., Bernier, A. V., Silverstein, J. H., WESTEN, S. C., & Elder, J. H. (2019) · JMIR Diabetes · doi:10.2196/13724 · Cited by 22
The interplay of type 1 diabetes and weight management: A qualitative study exploring thematic progression from adolescence to young adulthood
Addala, A., IGUDESMAN, D. A., Kahkoska, A. R., Muntis, F. R., Souris, K. J., Whitaker, K. J., Pratley, R. E., & Mayer‐Davis, E. J. (2019) · Pediatric Diabetes · doi:10.1111/pedi.12903 · Cited by 22
“lenging time for glycemic control.(9-11)These themes can also be used”
Background
A Practice in Maturation: Current Perspectives on the Transition from Pediatric to Adult Care for Young Adults with Diabetes
Sandler, C. N., & Garvey, K. C. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1247-x · Cited by 23
Role of Glucagon in Automated Insulin Delivery
Wilson, L. M., Jacobs, P. G., & Castle, J. R. (2019) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2019.10.008 · Cited by 23
Does Hashimoto's Thyroiditis Increase the Risk of Cardiovascular Disease in Young Type 1 Diabetic Patients?
Głowińska‐Olszewska, B., Borysewicz-Sańczyk, H., Sawicka, B., Klonowska, B., Charemska, D., Żelazowska‐Rutkowska, B., & Bossowski, A. T. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00431 · Cited by 25
“Unfortunately, this is a wellrecognized clinical problem that pediatric and young population is very problematic in keeping proper metabolic control even with modern technologies (61).”
Background
Survey on the use of insulin pumps in Italy: comparison between pediatric and adult age groups (IMITA study)
the Italian Study Group on Diffusion of CSII in Italy, Bonfanti, R., Lepore, G., Bozzetto, L., Corsi, A., Blasi, V. D., Girelli, A., Grassi, G., Iafusco, D., Rabbone, I., et al. (2015) · Acta Diabetologica · doi:10.1007/s00592-015-0810-4 · Cited by 21
“061 participants (8463\ 18 years old) demonstrated that an insulin pump was being used by 60 % of participants, ranging from a low of 55 % in 18- to 25-year-olds to 65 % in 6- to 12-year-olds [16].”
MethodResultInfluential
Diabetes distress in Indian children with type 1 diabetes mellitus and their mothers
Lohiya, N., Kajale, N., Lohiya, N. N., Khadilkar, V. V., Gondhalekar, K. M., & Khadilkar, A. V. (2020) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2020-0339 · Cited by 24
Efficacy and safety of the SGLT2 inhibitor dapagliflozin in type 1 diabetes: A meta‑analysis of randomized controlled trials
Huang, Y., Jiang, Z., & Wei, Y. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.9813 · Cited by 22
Understanding the Lived Experience of Children With Type 1 Diabetes in Kenya: Daily Routines and Adaptation Over Time
Palmer, T., Waliaula, C., Shannon, G. D., Salustri, F., Grewal, G., Chelagat, W., Jennings, H. M., & Skordis, J. (2021) · Qualitative Health Research · doi:10.1177/10497323211049775 · Cited by 21
“Additionally, whereas more advanced technology is commonplace in high income settings, with the uptake of insulin pumps exceeding 60% in the US (Miller et al., 2015), many children in Kenya struggle to afford the basics of needles and insulin.”
Background
“Fear That One Day I May Not Be Able to Afford Insulin”: The Emotional Burden of Diabetes Costs During Emerging Adulthood
Vitale, R. J., Wentzell, K., & Laffel, L. M. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2022.0170 · Cited by 21
Performance of a dual-hormone closed-loop system versus insulin-only closed-loop system in adolescents with type 1 diabetes. A single-blind, randomized, controlled, crossover trial
Lindkvist, E. B., Laugesen, C., Reenberg, A. T., Ritschel, T. K. S., Svensson, J., Jørgensen, J. B., Nørgaard, K., & Ranjan, A. G. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1073388 · Cited by 21
“However, achieving optimal metabolic control is challenging and many fail to meet recommended guidelines – especially adolescents (3).”
Background
Connected Insulin Pens and Caps: An Expert’s Recommendation from the Area of Diabetes of the Spanish Endocrinology and Nutrition Society (SEEN)
Pérez, C. T., Chico, A. I., Azriel-Mira, S., Lardiés‐Sánchez, B., Peralta, F. G., de Diabetes-SEEN, T. Á., Jesús, A. F. A., Rodrigo, A. B., Bellido, V., Bellido-Guerrero, D., et al. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01417-1 · Cited by 21
Who Should Be Considered for Islet Transplantation Alone?
Othonos, N., & Choudhary, P. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0847-6 · Cited by 21
Perceived peer support and diabetes management from adolescence into early emerging adulthood.
Pihlaskari, A. K., Wiebe, D. J., Troxel, N. R., Stewart, S. M., & Berg, C. A. (2018) · Health Psychology · doi:10.1037/hea0000662 · Cited by 21
“…materials: http://dx.doi.org/10.1037/hea0000662.supp The transition from late adolescence into early emerging adulthood is a time of risk for managing type 1 diabetes (T1D), as evidenced by poorer adherence and glycemic control compared with younger and older ages (Miller et al., 2015).”
Influential
The Development of Immunotherapy Strategies for the Treatment of Type 1 Diabetes
Coppieters, K. T., & von Herrath, M. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00283 · Cited by 21
“Despite continuing improvements in insulin therapy, the majority of patients fail to adequately control their glucose homeostasis (1), resulting in both short-term (hypoglycemia) and long term (nephropathy, retinopathy, neuropathy, and others) complications.”
Cost-effectiveness of Initiating an Insulin Pump in T1D Adults Using Continuous Glucose Monitoring Compared with Multiple Daily Insulin Injections: The DIAMOND Randomized Trial
Wan, W., Skandari, M. R., Minc, A., Nathan, A. G., Zarei, P., Winn, A. N., O’Grady, M. J., & Huang, E. S. (2018) · Medical Decision Making · doi:10.1177/0272989x18803109 · Cited by 22
“0%.(4) Persistent hyperglycemia increases the risk of developing acute and chronic diabetic complications(1,3) and thus increases the economic burden of diabetes.”
Identity and treatment adherence in predominantly ethnic minority teens and young adults with type 1 diabetes
COMMISSARIAT, P. V., Laffel, L. M., & Gonzalez, J. S. (2019) · Pediatric Diabetes · doi:10.1111/pedi.12932 · Cited by 21
“Research has found that diabetes management is particularly difficult during adolescence, a developmental period associated with substantially deteriorating glycemic control.(3,4) However, effective management of T1D should not be based solely on glycemic control or specific management behaviors.”
Background
Pilot Trial of a Sleep-Promoting Intervention for Children With Type 1 Diabetes
Jaser, S. S., Bergner, E. M., Hamburger, E., Bhatia, S. H., Lyttle, M., Bell, G. E., Slaughter, J. C., Malow, B. A., & Simmons, J. H. (2020) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsaa105 · Cited by 21
“In a recent national study, only 20% of children ages 6–12 were meeting the target of hemoglobin A1c (HbA1c) 7.5% (Miller et al., 2015), and with new recommended glycemic targets ( 7.0%, American Diabetes Association, 2020), it is likely that an even smaller percentage will meet treatment goals.”
BackgroundResultInfluential
Liraglutide for treating type 1 diabetes
Dejgaard, T. F., Frandsen, C. S., Holst, J. J., & Madsbad, S. (2016) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2016.1160050 · Cited by 21
“0%.[73] Some of the limitations of insulin therapy are large glucose fluctuations (with risk of hypoglycemia) and weight gain.”
Background
Long-term continuous glucose monitor use in very young children with type 1 diabetes: one-year results from the SENCE study
Van Name, M. A., Kanapka, L. G., DiMeglio, L. A., Miller, K. M., Albanese-O’Neill, A., Commissariat, P., Corathers, S. D., Harrington, K. R., Hilliard, M. E., Anderson, B. J., et al. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221084667 · Cited by 20
“45 % Time > 250 mg/dL 27 (22, 34) 30 (19, 40) 26 (20, 37) .”
Self-citation
Ambulatory glucose profile analysis of the juvenile diabetes research foundation continuous glucose monitoring dataset—Applications to the pediatric diabetes population
Forlenza, G. P., Pyle, L. L., Maahs, D. M., & Dunn, T. C. (2016) · Pediatric Diabetes · doi:10.1111/pedi.12474 · Cited by 20
“Beck, personal communication, May 2016).(11,12) CGM use may continue to become more common as realtime treatment decisions are increasingly made from non-adjunctive CGM data without fingerstick BG values.”
BackgroundSelf-citation
Recommendations for Initiating Use of Afrezza Inhaled Insulin in Individuals with Type 1 Diabetes
Pettus, J., Cavaiola, T. S., & Edelman, S. V. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0463 · Cited by 20
Adjunct Therapy in Type 1 Diabetes: A Survey to Uncover Unmet Needs and Patient Preferences Beyond HbA1c Measures
Pettus, J., Kushner, J. A., Valentine, V., Wood, R., Pang, C., Paranjape, S., Berria, R., Deluzio, A., & Edelman, S. V. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0027 · Cited by 22
Using Momentary Assessment and Machine Learning to Identify Barriers to Self-management in Type 1 Diabetes: Observational Study
Zhang, P., Fonnesbeck, C., Schmidt, D. C., White, J., Kleinberg, S., & Mulvaney, S. A. (2021) · JMIR mhealth and uhealth · doi:10.2196/21959 · Cited by 20
Improvement in glycemic control through changes in insulin regimens: findings from a Japanese cohort of children and adolescents with type 1 diabetes
Mochizuki, M., Kikuchi, T., Urakami, T., Kikuchi, N., Kawamura, T., Yokomichi, H., Hoshino, T., Matsuura, N., Sasaki, N., Sugihara, S., et al. (2016) · Pediatric Diabetes · doi:10.1111/pedi.12409 · Cited by 21
“female adolescents was poorer and more exacerbated than that in males.(9,42,43) These studies agree with the present results that have suggested improved, but worse glycemic control in female adolescents than that in male adolescents in the 1995 and 2000 cohorts(42)”
BackgroundResult
Resilient, Empowered, Active Living with Diabetes (REAL Diabetes) study: Methodology and baseline characteristics of a randomized controlled trial evaluating an occupation-based diabetes management intervention for young adults
Pyatak, E. A., Carandang, K. M., Vigen, C. L. P., Blanchard, J., Sequeira, P. A., Wood, J., Spruijt‐Metz, D., Whittemore, R., & Peters, A. L. (2017) · Contemporary Clinical Trials · doi:10.1016/j.cct.2016.12.025 · Cited by 20
“To adapt this framework to address the needs of the targeted population, our research team conducted a qualitative needs assessment amongst young adults with both T1D and T2D (23, 24), and developed and validated an intervention manual among a small sample of young adults with diabetes (25).”
BackgroundInfluential
Impact of an Automated Bihormonal Delivery System on Psychosocial Outcomes in Adults with Type 1 Diabetes
Weissberg-Benchell, J. A., Hessler, D., Fisher, L., Russell, S. J., & Polonsky, W. H. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0174 · Cited by 20
Children and adolescents with type 1 and type 2 diabetes mellitus in the Pediatric Diabetes Consortium Registries: comparing clinical characteristics and glycaemic control
Name, M. A. V., Cheng, P., Gal, R. L., Kollman, C., Lynch, J. L., Nelson, B., & Tamborlane, W. V. (2020) · Diabetic Medicine · doi:10.1111/dme.14233 · Cited by 20
Self-citation
Sodium–glucose cotransporter 2 inhibitors improved time‐in‐range without increasing hypoglycemia in Japanese patients with type 1 diabetes: A retrospective, single‐center, pilot study
Suzuki, D., Yamada, H., Yoshida, M., Funazaki, S., Amamoto, M., Morimoto, J., & Hara, K. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13240 · Cited by 19
Low uptake of continuous subcutaneous insulin infusion therapy in people with type 1 diabetes in Ireland: a retrospective cross-sectional study
Gajewska, K. A., Bennett, K., Biesma, R. G., & Sreenan, S. (2020) · BMC Endocrine Disorders · doi:10.1186/s12902-020-00573-w · Cited by 22
Candidate Selection for Hybrid Closed Loop Systems
Forlenza, G. P., Breton, M. D., & Kovatchev, B. P. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0217 · Cited by 20
Trajectory and predictors of HbA1c in children and adolescents with type 1 diabetes—A Danish nationwide cohort study
Ibfelt, E. H., Wibæk, R., Vistisen, D., Andersen, G. S., Jørgensen, M. E., Hulmán, Á., Dabelea, D., Birkebæk, N., Svensson, J., & Rønn, P. F. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13337 · Cited by 19
“In further large multicenter studies, HbA1c was also reported to increase with higher age group across childhood.(7,9,11) These studies did however not use repeated measurements, but categorizations or means of HbA1c in the analyses.”
Background
SGLT inhibition: a possible adjunctive treatment for type 1 diabetes
Aktürk, H. K., Rewers, A. H., & Garg, S. K. (2018) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000423 · Cited by 20
Association between Glycemic Control and Clinic Attendance in Emerging Adults with Type 1 Diabetes: A Tertiary Center Experience
Fisher, E., Lazar, L., Shalitin, S., Yackobovitch‐Gavan, M., de Vries, L., Oron, T., Tenenbaum, A., Phillip, M., & Lebenthal, Y. (2018) · Journal of Diabetes Research · doi:10.1155/2018/9572817 · Cited by 21
The Clinical Case for the Integration of a Ketone Sensor as Part of a Closed Loop Insulin Pump System
Lee, M. H., Paldus, B., Krishnamurthy, B., McAuley, S. A., Shah, R., Jenkins, A. J., & O’Neal, D. N. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818822986 · Cited by 22
Design and baseline data from a PCORI-funded randomized controlled trial of family-centered tailoring of diabetes self-management resources
Fiallo-Scharer, R. V., Palta, M., Chewning, B. A., Wysocki, T., Wetterneck, T. B., & COX, E. D. (2017) · Contemporary Clinical Trials · doi:10.1016/j.cct.2017.04.007 · Cited by 19
State and Trait Anxiety and Diabetes Outcomes in Youth With Type 1 Diabetes
Rechenberg, K., Szalacha, L. A., Salloum, A., & Grey, M. J. (2019) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721719866146 · Cited by 20
Can Short Bouts of Exercise (“Exercise Snacks”) Improve Body Composition in Adolescents with Type 1 Diabetes? A Feasibility Study
Hasan, R., Santiago, D. P., Churilla, J. R., Montes, B., Hossain, J., Mauras, N., & Darmaun, D. (2019) · Hormone Research in Paediatrics · doi:10.1159/000505328 · Cited by 19
Does Current Diabetes Technology Improve Metabolic Control? A Cross-Sectional Study on the Use of Insulin Pumps and Continuous Glucose Monitoring Devices in a Nationwide Pediatric Population
Bratke, H., Margeirsdottir, H. D., Assmus, J., Njølstad, P. R., & Skrivarhaug, T. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01127-6 · Cited by 20
Effectiveness and Safety of Insulin Glargine 300 U/ml in Comparison with Insulin Degludec 100 U/ml Evaluated with Continuous Glucose Monitoring in Adults with Type 1 Diabetes and Suboptimal Glycemic Control in Routine Clinical Practice: The OneCARE Study
Conget, I., Mangas, M. Á., Morales, C., Caro, J., Giménez, M., Borrell, M., & Delgado, E. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01153-4 · Cited by 19
“Achieving glycemic objectives recommended by scientific societies is accomplished in less than a third of patients with T1D [2].”
Background
Financial Barriers in Emerging Adults With Type 1 Diabetes: A Qualitative Analysis
Grigorian, E. G., Litchman, M. L., Porter, M. E., Blanchette, J. E., & Allen, N. A. (2022) · Diabetes Spectrum · doi:10.2337/ds21-0038 · Cited by 20
Glucagon‐like peptide‐1 agonists combined with sodium‐glucose cotransporter‐2 inhibitors reduce weight in type 1 diabetes
Al‐Ozairi, E., Irshad, M., Taghadom, E., SOJAN, L. G., Kandari, J. A., Alroudhan, D., & le Roux, C. W. (2023) · Obesity · doi:10.1002/oby.23677 · Cited by 20
“Usually, symptomatic hypoglycemia experienced by people with type 1 diabetes is, on average, two events per week [34].”
Background
Intelligent Insulin vs. Artificial Intelligence for Type 1 Diabetes: Will the Real Winner Please Stand Up?
Cambuli, V. M., & Baroni, M. G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713139 · Cited by 19
Diabetes distress in urban Black youth with type 1 diabetes and their caregivers: associations with glycemic control, depression, and health behaviors
Evans, M. A., Ellis, D. A., Vesco, A. T., Feldman, M. A., Weissberg-Benchell, J. A., Carcone, A. I., Miller, J. L., Boucher‐Berry, C., Buggs‐Saxton, C., Degnan, B., et al. (2024) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsad096 · Cited by 19
20 Years of insulin lispro in pediatric type 1 diabetes: a review of available evidence
Kaiserman, K. B., Jung, H., Benabbad, I., Karges, B., Polak, M., & Rosilio, M. (2016) · Pediatric Diabetes · doi:10.1111/pedi.12401 · Cited by 19
“than 1% of children in the United States who require insulin MDI or CSII treatment for type 1 diabetes still use regular human insulin as short-acting insulin (117).”
Background
Predictors of glycemic control in the first year of diagnosis of childhood onset type 1 diabetes: A systematic review of quantitative evidence
Paes, V. M., Charalampopoulos, D., Edge, J., Taylor-Robinson, D. C., Stephenson, T. J., & Amin, R. (2017) · Pediatric Diabetes · doi:10.1111/pedi.12530 · Cited by 22
Diabetes-specific family conflict: Informant discrepancies and the impact of parental factors.
Savin, K. L., Hamburger, E., Monzon, A. D., Patel, N. J., Perez, K. M., Lord, J. H., & Jaser, S. S. (2018) · Journal of Family Psychology · doi:10.1037/fam0000364 · Cited by 19
“…completed by parents, and adolescents’ shift toward independence and the associated increase in responsibility for diabetes management is often linked with less optimal glycemic control, with only 17% of adolescents meeting the ADA’s recommendation for glycemic control (Miller et al., 2015).”
Baseline Psychosocial Characteristics Predict Frequency of Continuous Glucose Monitoring in Youth with Type 1 Diabetes
McGill, D. E., Volkening, L. K., Butler, D. A., Harrington, K. R., Katz, M. L., & Laffel, L. M. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0037 · Cited by 21
Substance Use in Adults With Type 1 Diabetes in the T1D Exchange
Petry, N. M., Foster, N. C., Cengiz, E., Tamborlane, W. V., Wagner, J. A., & Polsky, S. (2018) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721718799088 · Cited by 19
Self-citation
Trajectories of hemoglobin A1c and body mass index z‐score over four decades among 2 to 18 year olds with type 1 diabetes
Moore, J. M., & Snell‐Bergeon, J. K. (2019) · Pediatric Diabetes · doi:10.1111/pedi.12862 · Cited by 19
Cost-effectiveness of Shared Telemedicine Appointments in Young Adults With T1D: CoYoT1 Trial
Wan, W., Nathan, A. G., Skandari, M. R., Zarei, P., Reid, M. W., Raymond, J. K., & Huang, E. S. (2019) · Diabetes Care · doi:10.2337/dc19-0363 · Cited by 19
E‐health education interventions on HbA1c in patients with type 1 diabetes on intensive insulin therapy: A systematic review and meta‐analysis of randomized controlled trials
Feigerlová, E., Oussalah, A., Zuily, S., Sordet, S., Braun, M., Guéant, J., & Guerci, B. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3313 · Cited by 21
Adjunct therapies in treatment of type 1 diabetes
Goyal, I., Sattar, A., Johnson, M., & Dandona, P. (2020) · Journal of Diabetes · doi:10.1111/1753-0407.13078 · Cited by 18
Sotagliflozin added to optimized insulin therapy leads to HbA1c reduction without weight gain in adults with type 1 diabetes: A pooled analysis of inTandem1 and inTandem2
Rodbard, H. W., Giaccari, A., Lajara, R., Stewart, J. A., Strumph, P., Oliveira, J. H., Lapuerta, P., & Castro, R. D. C. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14127 · Cited by 19
“The weight gain caused by insulin use could further contribute to the increasing overweight and obesity trends observed in the T1D population in the United States and elsewhere.(1,4,5)”
BackgroundInfluential
Sodium–glucose cotransporter inhibitors as add‐on therapy in addition to insulin for type 1 diabetes mellitus: A meta‐analysis of randomized controlled trials
Zou, H., Liu, L., Guo, J., Wang, H., Liu, S., Xing, Y., Deng, C., Xiao, Y., & Zhou, Z. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13387 · Cited by 20
Gingival crevicular fluid biomarkers in type 1 diabetes mellitus: A case–control study
Sereti, M., Roy, M., Zekeridou, A., Gastaldi, G., & Giannopoulou, C. (2020) · Clinical and Experimental Dental Research · doi:10.1002/cre2.351 · Cited by 20
“…with T1D and aged between <4 and >75 years old, showed that HbA1c levels can vary considerably with age, with higher levels during childhood and adolescence, a gradual decline until 30 years of age followed by a plateau, and again a modest drop after 65 years of age (Miller et al., 2015).”
Background
Continuous Glucose Monitoring in Adolescent, Young Adult, and Older Patients With Type 1 Diabetes
Agarwal, S., & Cappola, A. R. (2020) · JAMA · doi:10.1001/jama.2020.7058 · Cited by 19
All-cause mortality after hypoglycemic and hyperglycemic emergencies among U.S. adults with diabetes, 2011–2020
McCoy, R. G., Herrin, J., Galindo, R. J., Sindhu Swarna, K., Umpierrez, G. E., Hill Golden, S., & O'Connor, P. J. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110263 · Cited by 20
Effects of Sotagliflozin Combined with Intensive Insulin Therapy in Young Adults with Poorly Controlled Type 1 Diabetes: The JDRF Sotagliflozin Study
Bode, B. W., Cengiz, E., Wadwa, R. P., Banks, P., Danne, T., Kushner, J. A., McGuire, D. K., Peters, A. L., Strumph, P., & Sawhney, S. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0079 · Cited by 20
Addressing Unmet Medical Needs in Type 1 Diabetes: A Review of Drugs Under Development
Mittermayer, F., Caveney, E. J., OLIVEIRA, C. D. F., Fleming, G. A., Gourgiotis, L., Puri, M., Tai, L.-J., & Turner, J. R. (2016) · Current Diabetes Reviews · doi:10.2174/1573399812666160413115655 · Cited by 19
Prolonged lapses between pediatric and adult care are associated with rise in HbA1c and inpatient days among patients with type 1 diabetes
Tilden, D. R., French, B. C., Shoemaker, A. H., Corathers, S. D., & Jaser, S. S. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.110113 · Cited by 21
Virtual Peer Groups Reduce HbA1c and Increase Continuous Glucose Monitor Use in Adolescents and Young Adults with Type 1 Diabetes
Bisno, D. I., Reid, M. W., Pyatak, E. A., Garcia, J. F., Salcedo-Rodriguez, E., Sanchez, A. T., Fox, D. S., Hiyari, S., Fogel, J. L., Marshall, I., et al. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0199 · Cited by 21
“6 Less than one in ﬁve AYA have HbA1c levels consistent with recommendations from the American Diabetes Association (ADA), 7 suggesting that current models of care do not meet the needs of most AYA with T1D.”
Continuous glucose monitoring: a systematic review of sensor systems and prospects
Ray, P. P. (2018) · Sensor Review · doi:10.1108/sr-12-2017-0268 · Cited by 18
Does sleep duration, napping, and social jetlag predict hemoglobin A1c among college students with type 1 diabetes mellitus?
Saylor, J. L., Ji, X., Calamaro, C., & Davey, A. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.01.007 · Cited by 20
“2% [1], which is also the common age of college transition.”
Background
Declining Frequency of Acute Complications Associated with Tubeless Insulin Pump Use: Data from 2,911 Patients in the German/Austrian Diabetes Patienten Verlaufsdokumentation Registry
Biester, T., Schwandt, A., Heidtmann, B., Rami-Merhar, B. M., Haak, T., Festa, A., Kostow, S., Müller, A., Mönkemöller, K., Danne, T., et al. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0675 · Cited by 19
“This ﬁnding of low SH (coma) is also consistent with previous research in which a signiﬁcantly lower frequency of SH with insulin pump use has been observed compared with MDI.”
Influential
Felix dies natalis, insulin… ceterum autem censeo “beta is better”
Piemonti, L. (2021) · Acta Diabetologica · doi:10.1007/s00592-021-01737-3 · Cited by 18
State of Type 1 Diabetes Care in the United States in 2016–2018 from T1D Exchange Registry Data
Rodbard, D. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0008 · Cited by 18
A Systematic Review of Interventions for the Transition to Adult Healthcare for Young People with Diabetes
DeLacey, S. E., Papadakis, J. L., James, S., Cudizio, L., Ng, S. M., Lyons, S. K., Maruthur, N. M., Araszkiewicz, A., Gomber, A., Snoek, F. J., et al. (2025) · Current Diabetes Reports · doi:10.1007/s11892-025-01578-2 · Cited by 20
T-Cell Expression and Release of Kidney Injury Molecule-1 in Response to Glucose Variations Initiates Kidney Injury in Early Diabetes
Forbes, J. M., McCarthy, D. A., Kassianos, A. J., Baskerville, T., Fotheringham, A. K., Giuliani, K. T. K., Grivei, A., Murphy, A. J., Flynn, M., Sullivan, M. A., et al. (2021) · Diabetes · doi:10.2337/db20-1081 · Cited by 17
Effectiveness of Internet and Phone‐Based Interventions on Diabetes Management of Children and Adolescents With Type 1 Diabetes: A Systematic Review
Zhao, X., Huang, H., & Zheng, S. (2021) · Worldviews on Evidence-Based Nursing · doi:10.1111/wvn.12511 · Cited by 20
Cost-effectiveness of the tubeless automated insulin delivery system vs standard of care in the management of type 1 diabetes in the United States
BISKUPIAK, J. E., Ramos, M., Levy, C. J., Forlenza, G. P., Hopley, C. D. J., Boyd, J., Swift, D., Lamotte, M., & Brixner, D. I. (2023) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2023.22331 · Cited by 18
Design Considerations for Artificial Pancreas Pivotal Studies
Russell, S. J., & Beck, R. W. (2015) · Diabetes Care · doi:10.2337/dc15-2449 · Cited by 17
Self-citation
Keeping Up with the Diabetes Technology: 2016 Endocrine Society Guidelines of Insulin Pump Therapy and Continuous Glucose Monitor Management of Diabetes
Galderisi, A., Tremblay, E. S., & Cengiz, E. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0944-6 · Cited by 18
Duration of Catheter Use in Patients with Diabetes Using Continuous Subcutaneous Insulin Infusion: A Review
Bonato, L., Taleb, N., Gingras, V., Messier, V., Gobeil, F., Ménard, J., Ardilouze, J., & RABASA-LHORET, R. P. R. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0110 · Cited by 19
“4,5 6–8 Moreover, the insulin pump is an important component of the external artiﬁcial pancreas, which combines CSII with a glucose sensor and a dosing algorithm.”
Long-Term Safety of α-1 Antitrypsin Therapy in Children and Adolescents with Type 1 Diabetes
Brener, A., Lebenthal, Y., Interator, H., Horesh, O., Leshem, A., Weintrob, N., Loewenthal, N., Shalitin, S., & Rachmiel, M. (2018) · Immunotherapy · doi:10.2217/imt-2018-0047 · Cited by 17
Structural model of patient-centered communication and diabetes management in early emerging adults at the transfer to adult care
Baker, A. C., Wiebe, D. J., Kelly, C. S., Munion, A. K., Butner, J., Swinyard, M. T., Murray, M. A., & Berg, C. A. (2019) · Journal of Behavioral Medicine · doi:10.1007/s10865-019-00012-9 · Cited by 19
“…time when young people are managing diabetes more independently from parents (Hanna et al., 2013), and experience changing relationships with providers as they transfer from long-standing relationships with pediatric providers to new relationships with adult care providers (Monaghan et al., 2015).”
Influential
Medical and Psychological Considerations for Carbohydrate-Restricted Diets in Youth With Type 1 Diabetes
Gallagher, K. A. S., DeSalvo, D. J., Gregory, J. M., & Hilliard, M. E. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1153-2 · Cited by 20
Effect of 6 months’ flash glucose monitoring in adolescents and young adults with type 1 diabetes and suboptimal glycaemic control: managing diabetes in a ‘flash’ randomised controlled trial protocol
Styles, S. E., Gray, A. R., de Bock, M. I., Wiltshire, E. J., Galland, B. C., Tomlinson, P. A., Rayns, J. A., MacKenzie, K. E., & Wheeler, B. J. (2019) · BMC Endocrine Disorders · doi:10.1186/s12902-019-0378-z · Cited by 17
“Adolescence is a high-risk period where glycaemic control is at its worst [18], treatment adherence is a particular challenge [19] and the strain of self-management takes a toll on adolescents’ and their parents’ quality of life [20].”
Background
Diabetes‐specific self‐esteem, self‐care and glycaemic control among adolescents with Type 1 diabetes
Kenowitz, J., Hoogendoorn, C. J., COMMISSARIAT, P. V., & Gonzalez, J. S. (2019) · Diabetic Medicine · doi:10.1111/dme.14056 · Cited by 21
RT-CGM in adults with type 1 diabetes improves both glycaemic and patient-reported outcomes, but independent of each other
Nefs, G., Bazelmans, E., Marsman, D. E., Snellen, N., Tack, C. J., & de Galan, B. E. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107910 · Cited by 17
The association between dispositional mindfulness and glycemic control in type 1 diabetes during early adulthood: Differences by age and adverse childhood experiences
Nagel, K. E., Dearth‐Wesley, T., Herman, A. N., Smith, H. G., Gandica, R., Golden, L., Weil, H., & Whitaker, R. C. (2020) · Pediatric Diabetes · doi:10.1111/pedi.13000 · Cited by 17
Effectiveness of a WeChat Combined Continuous Flash Glucose Monitoring System on Glycemic Control in Juvenile Type 1 Diabetes Mellitus Management: Randomized Controlled Trial
Xu, Y., Xu, L., Zhao, W., Li, Q., Li, M., Lu, W., Zeng, H., Yan, J., Yang, D., Wu, W., et al. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s299070 · Cited by 17
Banting Memorial Lecture 2016 Reducing lifetime risk of complications in adolescents with Type 1 diabetes
Dunger, D. B. (2016) · Diabetic Medicine · doi:10.1111/dme.13299 · Cited by 18
Using technology to advance type 1 diabetes care among women during the reproductive years and in pregnancy
Polsky, S., GIORDANO, D. A., Voelmle, M. K., Garcetti, R., & Garg, S. K. (2016) · Postgraduate Medicine · doi:10.1080/00325481.2016.1159910 · Cited by 16
“issue, or pump malfunction),[20,21] however data supports the contrary.[22,23] Thus, anyone using CSII should have a”
Result
Ready or not? Greater readiness for independent self‐care predicts better self‐management but not HbA1c in teens with type 1 diabetes
Goethals, E. R., Volkening, L. K., TINSLEY, L. J., & Laffel, L. M. (2020) · Diabetic Medicine · doi:10.1111/dme.14507 · Cited by 18
Temporal Trends for Diabetes Management and Glycemic Control Between 2010 and 2019 in Korean Children and Adolescents with Type 1 Diabetes
Choe, J., Won, S., Choe, Y., Park, S. H., Lee, Y. J., Lee, J. E., Lee, Y. A., Lim, H. H., Yoo, J. H., Lee, S. Y., et al. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0274 · Cited by 16
A perspective on treating type 1 diabetes mellitus before insulin is needed
Tatović, D., Narendran, P., & Dayan, C. M. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00816-5 · Cited by 22
Ca2+-Mediated Signaling Pathways: A Promising Target for the Successful Generation of Mature and Functional Stem Cell-Derived Pancreatic Beta Cells In Vitro
Mu-u-min, R., Diané, A., Allouch, A., & Al-Siddiqi, H. (2023) · Biomedicines · doi:10.3390/biomedicines11061577 · Cited by 17
Behavioral Patterns and Associations with Glucose Control During 12-Week Randomized Free-Living Clinical Trial of Day and Night Hybrid Closed-Loop Insulin Delivery in Adults with Type 1 Diabetes
Emami, A., Willinska, M. E., Thabit, H., Leelarathna, L., Hartnell, S., Dellweg, S., Benesch, C., Mader, J. K., Holzer, M., Kojzar, H., et al. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0307 · Cited by 16
Developing and Testing an Intervention to Reduce Distress in Mothers of Adolescents With Type 1 Diabetes
Jaser, S. S., Lord, J. H., Savin, K. L., Gruhn, M. A., & Rumburg, T. M. (2018) · Clinical Practice in Pediatric Psychology · doi:10.1037/cpp0000220 · Cited by 17
“…no t to be di ss em in at ed br oa dl y. Clinical Practice in Pediatric Psychology © 2018 American Psychological Association 2018, Vol. 6, No. 1, 19–30 2169-4826/18/$12.00 http://dx.doi.org/10.1037/cpp0000220 19 17% of adolescents were meeting recommended treatment targets (Miller et al., 2015).”
Influential
Experiences and real life management of insulin pump therapy in adults with type 1 diabetes
Quirós, C., Jansà, M., Viñals, C., Giménez, M., Roca, D., Escarrabill, J., Garcia, F., Pérez, S., & Conget, I. (2018) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2018.05.017 · Cited by 16
“This finding may indicates that CSII more active self-adjustments could be beneficial in terms of metabolic control.11,13 Regarding efficacy, on average, an HbA1c of 7.7%, with a value 7.5% in 43% of patients and 11% of SMBG 70 mg/dl could be considered satisfactory in comparison with previous reports of patients with…”
ResultInfluential
Is there an optimal strategy for real‐time continuous glucose monitoring in pediatrics? A 12‐month French multi‐center, prospective, controlled randomized trial (Start‐In!)
Guilmin‐Crépon, S., Carel, J., Schroedt, J., Sulmont, V., Salmon-Musial, A. S., Tallec, C. L., Coutant, R., Dalla‐Vale, F., Stuckens, C., Bony-Trifunovic, H., et al. (2019) · Pediatric Diabetes · doi:10.1111/pedi.12820 · Cited by 17

Authors: Miller, K. M., Foster, N. C., Beck, R. W., Bergenstal, R. M., DuBose, S. N., DiMeglio, L. A., Maahs, D. M., & Tamborlane, W. V.
Affiliations: Jaeb Center for Health Research (US)
Park Nicollet Health Services (US)
Indiana University School of Medicine (US)
Barbara Davis Center for Childhood Diabetes, Aurora, CO
Yale University (US)
Corresponding author: Miller, Kellee M.
ORCID: Miller, Kellee M.
Foster, Nicole C.
Beck, Roy W.
Bergenstal, Richard M.
DuBose, Stephanie N.
DiMeglio, Linda A.
Maahs, David M.
Tamborlane, William V.
Venue: Diabetes Care
Publisher: American Diabetes Association
Published: 2015-05-12
Volume: 38
Issue: 6
Pages: 971-978
ISSN: 0149-5992 (ISSN-L)
1935-5548
DOI: 10.2337/dc15-0078
OpenAlex: W2098570086
Cited by: 1,254
References: 25
Citations by year: 2026: 35 · 2025: 55 · 2024: 64 · 2023: 88 · 2022: 81 · 2021: 134 · 2020: 157 · 2019: 198 · 2018: 176 · 2017: 138 · 2016: 108 · 2015: 19
FWCI: 127.79
Type: journal article
Language: en
Open access: closed
Licence: www.diabetesjournals.org/site/license (vor, 203 d)
Locations: Diabetes Care (publishedVersion)
PubMed (publishedVersion)
Funders: Leona M. and Harry B. Helmsley Charitable Trust
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
Keywords: type 1 diabetes, glycemic control, HbA1c, severe hypoglycemia, diabetic ketoacidosis, insulin pump therapy, continuous glucose monitoring, diabetes technology, age trends
MeSH terms: Adolescent, Adult, Aged, Child, Child, Preschool, Diabetes Mellitus, Type 1, Health Services Needs and Demand, Glycated Hemoglobin, Humans, Insulin Infusion Systems, Male, Middle Aged, Registries, United States, Blood Glucose Self-Monitoring, Comorbidity, Diabetic Ketoacidosis, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Current State of Type 1 Diabetes Treatment in the U.S.: Updated Data From the T1D Exchange Clinic Registry

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Citations

Cites

Cited by

Related

Metadata

Record

About these checks